Detalhe da pesquisa
1.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
2.
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.
Blood
; 139(8): 1135-1146, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543383
3.
Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
Eur J Haematol
; 112(3): 424-432, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929654
4.
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Haematologica
; 108(3): 705-716, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226495
5.
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring.
Ann Hematol
; 102(11): 3133-3141, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480389
6.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
7.
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Int J Mol Sci
; 24(15)2023 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569479
8.
ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations.
Genes Chromosomes Cancer
; 61(7): 399-411, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083818
9.
Oncology stewardship in acute myeloid leukemia.
Ann Hematol
; 101(8): 1627-1644, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618780
10.
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
J Natl Compr Canc Netw
; 20(3): 245-252, 2022 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120305
11.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Am J Hematol
; 97(3): 322-328, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981560
12.
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
J Oncol Pharm Pract
; 28(6): 1315-1325, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074182
13.
Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.
J Natl Compr Canc Netw
; 19(11): 1272-1275, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404029
14.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
15.
Utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
Transpl Infect Dis
; 23(4): e13612, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825279
16.
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
Blood
; 132(11): 1125-1133, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045838
17.
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
Blood
; 131(4): 387-396, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196412
18.
Cytogenomic array detects a subset of myelodysplastic syndrome with increased risk that is invisible to conventional karyotype.
Genes Chromosomes Cancer
; 58(11): 756-774, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31334569
19.
CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
PLoS Pathog
; 13(7): e1006509, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732051
20.
The leukemia strikes back: a review of pathogenesis and treatment of secondary AML.
Ann Hematol
; 98(3): 541-559, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666431